SKF-89,626

SKF-89,626

SKF-89,626 is a synthetic compound that acts as a selective agonist for the dopamine D1 receptor. It is primarily used in scientific research to study the role of D1 receptors in the brain and their involvement in various neurological and psychiatric conditions.

Chemical Structure and Properties

SKF-89,626 is chemically classified as a benzazepine derivative. Its IUPAC name is 6-chloro-7,8-dihydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine. The compound has a molecular formula of C17H18ClNO2 and a molecular weight of 303.79 g/mol.

Pharmacology

SKF-89,626 is known for its high affinity and selectivity for the dopamine D1 receptor, a subtype of dopamine receptor that is primarily expressed in the central nervous system. Activation of D1 receptors by SKF-89,626 leads to increased production of cyclic AMP (cAMP) within neurons, which is a key second messenger involved in many cellular processes.

Mechanism of Action

As a D1 receptor agonist, SKF-89,626 mimics the action of dopamine by binding to the D1 receptor and activating it. This activation results in the stimulation of adenylate cyclase, an enzyme that converts ATP to cAMP. The increase in cAMP levels subsequently activates protein kinase A (PKA), which phosphorylates various target proteins, leading to changes in neuronal activity and gene expression.

Research Applications

SKF-89,626 is widely used in research to explore the role of D1 receptors in:

• Cognition and Memory: Studies have shown that D1 receptor activation can enhance cognitive functions such as working memory and attention.
• Motor Control: D1 receptors are involved in the regulation of motor activity, and SKF-89,626 is used to study disorders like Parkinson's disease.
• Psychiatric Disorders: Research on SKF-89,626 helps in understanding the pathophysiology of schizophrenia and other mood disorders where dopamine dysregulation is implicated.

Safety and Toxicology

While SKF-89,626 is a valuable research tool, it is not approved for clinical use in humans. Studies in animal models have shown that excessive activation of D1 receptors can lead to adverse effects such as hyperactivity and stereotypic behaviors.

Also see

• Dopamine receptor
• D1 receptor
• Dopamine agonist
• Cyclic AMP
• Neurotransmitter

External Links

• [PubChem Entry for SKF-89,626](https://pubchem.ncbi.nlm.nih.gov/compound/SKF-89_626)
• [ResearchGate Publications on SKF-89,626](https://www.researchgate.net/topic/SKF-89_626)